You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DNMT

Showing 1 - 25 of 103
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Index Colonoscopy to Predict Polyp Recurrence During

Completed
  • Colon Polyp
    • (no location specified)
    Oct 3, 2022

    DNA Methylation and Histone Modification in H. Pylori Associated

    Recruiting
    • Gastric Carcinoma
    • Immunohistochemical staining for DNMT1 and EZH2
    • Assiut, Egypt
      Assiut University
    Mar 31, 2023

    High Risk Myelodysplastic Syndrome Trial in Houston (Guadecitabine)

    Active, not recruiting
    • High Risk Myelodysplastic Syndrome
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 2, 2022

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Birmingham (NTX-301)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Dec 6, 2021

    Tuberculosis, Pulmonary Trial in Houston (Azacitidine Injection)

    Not yet recruiting
    • Tuberculosis, Pulmonary
    • Azacitidine Injection
    • Houston, Texas
      Harris Health System - Ben Taub Hospital
    Sep 1, 2022

    Untreated Adult Acute Myeloid Leukemia Trial in Houston (Cladribine, Guadecitabine, Idarubicin)

    Completed
    Has Results
    • Untreated Adult Acute Myeloid Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 28, 2022

    Clinical Relevance of DNMT and HDAC Gene SNP on Response to

    Completed
    • Myelodysplastic Syndrome
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Aug 11, 2020

      Colorectal Adenocarcinoma, CpG Island Methylator Phenotype, Metastatic Microsatellite Stable Colorectal Carcinoma Trial in Los

      Withdrawn
      • Colorectal Adenocarcinoma
      • +7 more
      • Los Angeles, California
      • +1 more
      Apr 1, 2021

      Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

      Active, not recruiting
      • Platinum-Resistant Fallopian Tube Carcinoma
      • +5 more
      • Tucson, Arizona
      • +16 more
      Oct 19, 2022

      Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)

      Recruiting
      • Newly Diagnosed Peripheral T-cell Lymphoma
      • Nanjing, Jiangsu, China
        Hematological Department, People's Hospital of Jiangsu Province
      Jun 1, 2023

      Locally Advanced Unresectable Primary Central Chondrosarcoma, Metastatic Primary Central Chondrosarcoma, Unresectable Primary

      Suspended
      • Locally Advanced Unresectable Primary Central Chondrosarcoma
      • +2 more
      • Phoenix, Arizona
      • +38 more
      Feb 2, 2023

      Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

      Not yet recruiting
      • Mesothelioma
      • +5 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 1, 2023

      People Who Have Genetic Changes and Features of Autism: Simons

      Recruiting
      • 16P11.2 Deletion Syndrome
      • +184 more
        • New York, New York
        • +1 more
        Jan 6, 2023

        Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)

        Recruiting
        • Neoplasms
        • Solid Tumors
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 23, 2023

        Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Myelodysplastic Syndromes
        • (no location specified)
        Mar 1, 2023

        Effect of DNMT SNPs on DNA Methylation in Primary ITP

        Unknown status
        • Primary Immune Thrombocytopenia
        • Global DNA methylation will be quantified in the DNA samples by colorimetry
        • (no location specified)
        Sep 23, 2019

        Tumors Trial run by the National Cancer Institute (NCI) (FdCyd + THU)

        Completed
        • Neoplasms
        • FdCyd + THU
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 24, 2023

        MDS, MDS/MPN Crossover Syndromes Trial in Cleveland (5-azacytidine, Decitabine)

        Recruiting
        • Myelodysplastic Syndromes
        • MDS/MPN Crossover Syndromes
        • Cleveland, Ohio
          Cleveland Medical Center, University Hospitals Seidman Cancer Ce
        Aug 10, 2022

        Tumors, Solid Tumors Trial run by the NCI (TdCyd)

        Suspended
        • Neoplasms
        • Solid Tumors
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 6, 2022

        CHIP in Endothelial Dysfunction Associated With HEpEF

        Not yet recruiting
        • Heart Failure With Preserved Ejection Fraction
          • (no location specified)
          Apr 12, 2023

          Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

          Not yet recruiting
          • Anatomic Stage III Breast Cancer AJCC v8
          • +3 more
          • Biopsy
          • +4 more
          • (no location specified)
          Jan 4, 2023

          Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Hodgkin Lymphoma Trial in New York (Decitabine and

          Recruiting
          • Recurrent B-Cell Non-Hodgkin Lymphoma
          • +5 more
          • Decitabine and Cedazuridine
          • Nivolumab
          • New York, New York
            NY011 Laura and Isaac Perlmutter Cancer Center at NYU Langone
          Jul 8, 2022

          Obesity, Lupus Erythematosus Trial in Sao Paulo (Vitamin B12 + folic acid supplementation, Placebo supplementation)

          Not yet recruiting
          • Obesity
          • Lupus Erythematosus
          • Vitamin B12 + folic acid supplementation
          • Placebo supplementation
          • Sao Paulo, Brazil
            Univsersity of Sao Paulo
          Oct 15, 2021

          Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

          Active, not recruiting
          • Chronic Myelomonocytic Leukemia
          • Leukemia
          • Tampa, Florida
          • +4 more
          Nov 11, 2022

          Clonal Hematopoiesis of Indeterminate Potential in Venous

          Active, not recruiting
          • Venous Thromboembolism
            • Nîmes, France
              CHU de Nimes
            Jan 24, 2022